Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes

Diabetes

Volumn 61, Issue 6, 2012, Pages 1543-1551

  Gao, Jie ^a   He, Jinhan ^a   Shi, Xiongjie ^a   Stefanovic Racic, Maja ^b   Xu, Meishu ^a   O'Doherty, Robert Martin ^b   Garcia Ocana, Adolfo ^b   Xie, Wen ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESTROGEN; ESTROGEN SULFOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; ENERGY EXPENDITURE; ENERGY METABOLISM; ESTROGEN ACTIVITY; FATTY LIVER; FEMALE; GLUCONEOGENESIS; INFLAMMATION; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; LIPOGENESIS; LIVER; MACROPHAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARIECTOMY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; CALORIMETRY, INDIRECT; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY LIVER; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPOTHALAMUS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, OBESE; MUSCLE, SKELETAL; SEX FACTORS; SULFOTRANSFERASES;

EID: 84861867457     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1152     Document Type: Article

References (38)

1. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 2000;97:12735-12740
2. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000;97:12729-12734
3. Musatov S, Chen W, Pfaff DW, et al. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 2007;104:2501-2506 (Pubitemid 46391425)
4. Ribas V, Nguyen MT, Henstridge DC, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 2010;298:E304-E319
5. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009;150:2109-2117
6. Gao H, Bryzgalova G, Hedman E, et al. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol 2006;20:1287-1299 (Pubitemid 43801232)
7. Hobkirk R. Steroid sulfation Current concepts. Trends Endocrinol Metab 1993;4:69-74
8. Qian YM, Sun XJ, Tong MH, Li XP, Richa J, Song WC. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 2001;142:5342-5350 (Pubitemid 33131967)
9. Tong MH, Jiang H, Liu P, Lawson JA, Brass LF, Song WC. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice. Nat Med 2005;11:153-159 (Pubitemid 40321350)
10. Gong H, Guo P, Zhai Y, et al. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 2007;21:1781-1790 (Pubitemid 47173791)
11. Gong H, Jarzynka MJ, Cole TJ, et al. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 2008;68:7386-7393
12. Leiter EH, Chapman HD. Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes. J Clin Invest 1994;93:2007-2013 (Pubitemid 24143080)
13. Song WC, Moore R, McLachlan JA, Negishi M. Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant liver expression in obese and diabetogenic C57BL/KsJ-db/db mice. Endocrinology 1995;136:2477-2484
14. Leiter EH, Chapman HD, Falany CN. Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice. Diabetes 1991;40:1360-1363
15. Wittmers LE Jr, Haller EW. Effect of adrenalectomy on the metabolism of glucose in obese (C57 Bl/6J ob/ob) mice. Metabolism 1983;32:1093-1100 (Pubitemid 14215816)
16. Gill AM, Leiter EH, Powell JG, Chapman HD, Yen TT. Dexamethasone-induced hyperglycemia in obese Avy/a (viable yellow) female mice entails preferential induction of a hepatic estrogen sulfotransferase. Diabetes 1994;43:999-1004
17. Kim JK. Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods Mol Biol 2009;560:221-238
18. García-Ocaña A, Vasavada RC, Cebrian A, et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 2001;50:2752-2762 (Pubitemid 33733126)
19. Gao J, He J, Zhai Y, Wada T, Xie W. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 2009;284:25984-25992
20. Velazquez-Garcia S, Valle S, Rosa TC, et al. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation. Diabetes 2011;60:2546-2559
21. Ng KY, Yong J, Chakraborty TR. Estrous cycle in ob/ob and ovariectomized female mice and its relation with estrogen and leptin. Physiol Behav 2010;99:125-130
22. Ohlsson C, Mohan S, Sjögren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009;30:494-535
23. Bartell SM, Rayalam S, Ambati S, et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res 2011;26:1710-1720
24. Butler AA, Kozak LP. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 2010;59:323-329
25. Kester MH, van Dijk CH, Tibboel D, et al. Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab 1999;84:2577-2580
26. Li L, Falany CN. Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins. J Cyst Fibros 2007;6:23-30 (Pubitemid 46039451)
27. Moran A, Pyzdrowski KL, Weinreb J, et al. Insulin sensitivity in cystic fi- brosis. Diabetes 1994;43:1020-1026
28. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994;79:80-85 (Pubitemid 24221164)
29. Harris RM, Wood DM, Bottomley L, et al. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 2004;89:1779-1787 (Pubitemid 38507934)
30. Musarò A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999;400:581-585 (Pubitemid 29381809)
31. Della Torre S, Rando G, Meda C, et al. Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab 2011;13:205-214
32. Liu S, Mauvais-Jarvis F. Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology 2010;151:859-864
33. Khor VK, Tong MH, Qian Y, Song WC. Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse. Endocrinology 2008;149:5440-5448
34. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973;9:287-293
35. Ribas V, Drew BG, Le JA, et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA 2011;108:16457-16462
36. Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 2011;22:24-33
37. Khor VK, Dhir R, Yin X, Ahima RS, Song WC. Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice. Am J Physiol Endocrinol Metab 2010;299:E657-E664
38. Wada T, Ihunnah CA, Gao J, et al. Estrogen sulfotransferase inhibits adipocyte differentiation. Mol Endocrinol 2011;25:1612-1623